Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bowers

Showing results (251-260 of 255) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 255 results.
Nature Genetics|February 2, 2016
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanismPratiti Bandopadhayay, Lori A Ramkissoon, Payal Jain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Nature Medicine|January 7, 2022
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiencyAnirban Das, Sumedha Sudhaman, Daniel Morgenstern, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Pageof 26

Showing results (251-260 of 255) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 255 results.
Nature Genetics|February 2, 2016
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanismPratiti Bandopadhayay, Lori A Ramkissoon, Payal Jain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Nature Medicine|January 7, 2022
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiencyAnirban Das, Sumedha Sudhaman, Daniel Morgenstern, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Pageof 26